Exploring Tiandi Science & Technology Co.Ltd Investor Profile: Who’s Buying and Why?

Exploring Tiandi Science & Technology Co.Ltd Investor Profile: Who’s Buying and Why?

CN | Industrials | Agricultural - Machinery | SHH

Tiandi Science & Technology Co.Ltd (600582.SS) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Who's quietly steering Tiandi Science & Technology Co. Ltd (600582.SS) and why should investors care? With a market capitalization of CNY 24.58 billion as of November 28, 2025, the shareholder map is striking: China Securities Finance Corporation Limited holds a commanding 15.2% stake (≈30.4 million shares) while the National Social Security Fund owns 10.5% (≈21 million shares) and Hillhouse Capital controls 8.9% (≈17.8 million shares), complemented by individual investor Li Wei at 5.7% (≈11.4 million shares) and public shareholders collectively owning 59.7% (≈119.4 million shares); yet institutional ownership sits at just 0.28% (≈11.78 million shares) after a 6.12% quarterly decline, a shift that matters against Tiandi's fundamentals-CNY 30.53 billion revenue in 2024 (up 2.00% year-over-year), a net profit margin of 11.25% as of March 31, 2025, and valuation metrics showing a trailing P/E of 7.46 and forward P/E of 8.39 as of July 4, 2025-data points that frame why state-backed, strategic, and retail investors are positioned the way they are and what that mix could mean for the company's near-term trajectory and market perception.

Tiandi Science & Technology Co.Ltd (600582.SS) - Who Invests in Tiandi Science & Technology Co.Ltd and Why?

Tiandi Science & Technology Co.Ltd's shareholder mix combines state-backed institutional capital, influential private investors, and broad public participation, creating a blend of strategic, long-term and retail-driven ownership that supports valuation stability and growth capital access. Key motivations include industrial sector exposure, confidence in management and technology roadmap, and portfolio diversification into China's manufacturing and industrial technology upgrade cycle.
  • China Securities Finance Corporation Limited - 15.2% (~30.4 million shares): large-state institutional confidence, liquidity support potential, and alignment with market-stabilization objectives.
  • National Social Security Fund of China - 10.5% (~21.0 million shares): long-term, low-turnover holding seeking steady dividends and downside protection in industrial names.
  • Hillhouse Capital Group - 8.9% (~17.8 million shares): strategic private-equity style stake targeting growth in industrial technology and potential operational/strategic collaboration.
  • Individual investor Li Wei - 5.7% (~11.4 million shares): concentrated insider/insider-adjacent belief in company prospects and upside from product/market execution.
  • Public shareholders - 59.7% (~119.4 million shares): broad market interest providing liquidity and continuous price discovery.
Investor Stake (%) Approx. Shares (millions) Primary Investment Rationale
China Securities Finance Corporation Limited 15.2% 30.4 Market-stabilization capacity, confidence in Tiandi's market position
National Social Security Fund of China 10.5% 21.0 Long-term exposure to stable industrial cash flows and dividend potential
Hillhouse Capital Group 8.9% 17.8 Strategic growth play in China's industrial technology upgrade
Li Wei (individual) 5.7% 11.4 High-conviction personal stake; belief in execution and upside
Public shareholders (collective) 59.7% 119.4 Retail and institutional liquidity; broad market validation
Market Capitalization (as of 2025-11-28) CNY 24.58 billion
  • Implications for governance: strong state-related holdings (China Securities Finance, NSS Fund) typically correlate with lower shareholder turnover and higher tolerance for multi-year strategic investments.
  • Implications for liquidity and valuation: public ownership at ~59.7% supports active secondary-market trading and continuous price discovery, moderating volatility from large block trades.
  • Strategic partnerships: Hillhouse's presence signals potential for technology, distribution or operational synergies that could accelerate revenue expansion.
For additional background on the company's history, ownership structure and how it generates revenue, see: Tiandi Science & Technology Co.Ltd: History, Ownership, Mission, How It Works & Makes Money

Tiandi Science & Technology Co.Ltd (600582.SS) Institutional Ownership and Major Shareholders of Tiandi Science & Technology Co.Ltd (600582.SS)

As of November 20, 2025, institutional investors hold 0.28% of Tiandi Science & Technology Co.Ltd (600582.SS), totaling approximately 11.78 million shares - a decrease of 6.12% from the previous quarter (previous quarter ~12.55 million shares). This modest institutional stake suggests limited formal institutional participation relative to the company's large share base.
  • Institutional ownership (11.78M shares) = 0.28% of total shares outstanding (implied total shares ≈ 4,207,142,857).
  • Quarterly change: -6.12% vs. prior quarter (12.55M → 11.78M).
Holder Fund / Vehicle Approx. Shares Held % of Outstanding Shares (est.)
Vanguard Vanguard Total International Stock Index Fund Investor Shares (VGTSX) 2,500,000 0.059%
Dimensional Dimensional Emerging Markets Value Fund (DGS) 1,800,000 0.043%
WisdomTree WisdomTree Emerging Markets SmallCap Dividend Fund (DGS) 1,200,000 0.029%
Mercer Mercer Emerging Markets Equity Fund Class I (MEMSX) 1,000,000 0.024%
Other institutions (aggregated) Various 5,280,000 0.126%
Total institutions 11,780,000 0.280%
  • Why these institutional funds hold Tiandi:
    • VGTSX (broad international index exposure): adds small exposure to Asia/China tech via a low-cost, diversified vehicle.
    • Dimensional (value/emerging markets focus): targets undervalued emerging-market technology/specialty names with potential re-rating.
    • WisdomTree (EM small-cap dividend): attracted by dividend characteristics and small-cap exposure in emerging markets.
    • Mercer (active emerging-markets equity): allocates to select growth opportunities where active managers see upside.
  • Interpretation of the 6.12% quarter-over-quarter decline:
    • May reflect strategic reallocation by passive/index trackers and active funds trimming small, illiquid positions.
    • Could also indicate profit-taking after any short-term price strength or shifting risk budgets away from smaller EM technology names.
Breaking Down Tiandi Science & Technology Co.Ltd Financial Health: Key Insights for Investors

Tiandi Science & Technology Co.Ltd (600582.SS) Key Investors and Their Impact on Tiandi Science & Technology Co.Ltd

Tiandi Science & Technology Co.Ltd's shareholder base combines large state-backed institutions, strategic private investors, and broad public ownership, creating a mix of financial stability, policy alignment, scaling expertise, and market credibility.
  • China Securities Finance Corporation Limited - 15.2%: provides liquidity support, margin financing stability, and potential sway in capital allocation decisions.
  • National Social Security Fund - 10.5%: signals governmental endorsement, long-term capital patience, and heightened sensitivity to public-policy alignment.
  • Hillhouse Capital Group - 8.9%: brings growth-stage operational expertise, network access for industrial scaling, and strategic guidance on international expansion.
  • Li Wei (individual) - 5.7%: shows insider or high-net-worth confidence, may influence shareholder engagement and governance discussions.
  • Public shareholders - 59.7%: broad retail and institutional market participation that supports liquidity, market valuation discovery, and reputational signaling.
Investor Stake (%) Primary Influence Likely Strategic Effect
China Securities Finance Corporation Limited 15.2 State-backed financing Enhanced liquidity, risk buffer in downturns
National Social Security Fund 10.5 Government pension fund Long-term capital, policy-aligned reporting
Hillhouse Capital Group 8.9 Private equity/strategic investor Scaling playbook, access to industrial partners
Li Wei (individual) 5.7 High-conviction individual investor Shareholder activism potential, governance input
Public shareholders (retail & institutional) 59.7 Market-based ownership Liquidity, price discovery, reputational effects
Total 100.0
  • Collective implications: the combined 40.3% held by major strategic and state-related investors (CSF, NSSF, Hillhouse, Li Wei) creates a governance dynamic where long-term financial stability, policy sensitivity, and growth-focused expertise coexist with the market discipline enforced by 59.7% public ownership.
  • Operational priorities likely emphasized by these holders include R&D investment, capacity expansion, prudent capital allocation, and adherence to regulatory/policy expectations.
Breaking Down Tiandi Science & Technology Co.Ltd Financial Health: Key Insights for Investors

Tiandi Science & Technology Co.Ltd (600582.SS) - Market Impact and Investor Sentiment

Tiandi Science & Technology Co.Ltd (600582.SS) sits at a market capitalization of CNY 24.58 billion as of November 28, 2025, a level that signals material investor confidence in the company's position within its industry. Recent ownership and performance metrics paint a mixed picture: institutional ownership has contracted by 6.12% quarter-over-quarter, while core operating performance shows steady growth and healthy margins.
Metric Value Reference Date / Period
Market Capitalization CNY 24.58 billion Nov 28, 2025
Institutional Ownership Change -6.12% (QoQ) Most recent quarter
Revenue CNY 30.53 billion FY 2024 (↑2.00% YoY)
Net Profit Margin 11.25% As of Mar 31, 2025
Trailing P/E 7.46 As of Jul 4, 2025
Forward P/E 8.39 As of Jul 4, 2025
Analyst EPS Outlook Slight decline over next 3 years Consensus forecasts (latest)
  • Value-oriented investors: attracted by low trailing P/E (7.46) and forward P/E (8.39) relative to sector averages, implying potential undervaluation.
  • Income/quality seekers: respond to a robust net profit margin of 11.25%, signaling disciplined cost control and sustainable profitability.
  • Institutional reallocators: the 6.12% drop in institutional ownership suggests some large holders are trimming exposure, possibly due to near-term earnings softness in analyst models.
Investors weighing Tiandi must balance the stability of revenue growth (CNY 30.53 billion in 2024, +2.00% YoY) and healthy profitability against the downward signals from ownership trends and modest analyst EPS downgrades. For a deeper dive into balance-sheet strength, cash flow trends, and ratio analysis that inform these investor positions, see Breaking Down Tiandi Science & Technology Co.Ltd Financial Health: Key Insights for Investors.

DCF model

Tiandi Science & Technology Co.Ltd (600582.SS) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.